Related Experiment Video
Updated: Aug 7, 2026
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Animal and culture models of glaucoma for studying neuroprotection
1Dept. of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison 53792, USA.
Purpose:
Neuroprotection aims to treat nervous system disease by maintaining the health and function of neurons. The final proof of the neuroprotective strategy relies on randomized, controlled clinical trials, but the choice of which agents to study for these trials depends on studies in the laboratory using culture and animal models. Most culture models for studying ocular neuroprotection use retinal cells, and a range of mechanisms can be studied in culture, e.g. axotomy and serum or growth factor deprivation.
Methods:
A variety of animal models are available for studying neuroprotection as possible therapy for glaucomatous optic neuropathy. Those most closely related to glaucoma are probably associated with moderate elevation of the intraocular pressure to levels similar to those seen in patients with untreated glaucomatous optic neuropathy.
Conclusions:
Care should be taken when applying the results of these models to humans, and there is no single criterion for deciding which culture or animal model is most relevant to the clinical situation. The most important feature is whether the model's results correlate with clinical results, and this information will only become available over time, as randomized clinical trials are completed.
Insights
Choosing the right laboratory models is crucial for developing effective neuroprotection strategies. Correlation with clinical trial results is the key to validating these models for treating nervous system diseases.
Area of Science:
- Neuroscience
- Ophthalmology
Background:
- Neuroprotection strategies aim to preserve neuron health and function for treating nervous system diseases.
- Laboratory models, including cell cultures and animal studies, are essential for evaluating potential neuroprotective agents before clinical trials.
Purpose of the Study:
- To review the use of laboratory models in neuroprotection research, particularly for ocular conditions like glaucoma.
- To discuss the selection criteria and limitations of current cell culture and animal models for neuroprotection studies.
Main Methods:
- Utilizing retinal cell cultures to study mechanisms like axotomy and growth factor deprivation for ocular neuroprotection.
- Employing animal models, specifically those with moderate intraocular pressure elevation, to investigate neuroprotection for glaucomatous optic neuropathy.
Main Results:
- Cell culture models allow for the study of various neuroprotective mechanisms relevant to ocular conditions.
- Animal models mimicking elevated intraocular pressure provide a platform for testing neuroprotective therapies for glaucoma.
Conclusions:
- No single laboratory model is universally applicable; careful consideration is needed when extrapolating results to human patients.
- The ultimate validation of neuroprotection models relies on their correlation with outcomes from human randomized clinical trials, which requires long-term follow-up.
